Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,213 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $381.20 | 4 | $0 (2019) |
| GE HEALTHCARE | $138.16 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $130.51 | 1 | $0 (2018) |
| Gilead Sciences, Inc. | $120.00 | 1 | $0 (2020) |
| InSightec,Inc | $110.46 | 1 | $0 (2023) |
| ABBVIE INC. | $96.54 | 4 | $0 (2024) |
| Vertos Medical, Inc. | $77.74 | 1 | $0 (2019) |
| PFIZER INC. | $62.83 | 1 | $0 (2018) |
| Novo Nordisk Inc | $62.34 | 1 | $0 (2019) |
| NATUS MEDICAL INCORPORATED | $21.01 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.28 | 1 | ABBVIE INC. ($14.28) |
| 2023 | $192.72 | 4 | InSightec,Inc ($110.46) |
| 2020 | $141.01 | 2 | Gilead Sciences, Inc. ($120.00) |
| 2019 | $265.08 | 3 | Sunovion Pharmaceuticals Inc. ($125.00) |
| 2018 | $351.28 | 5 | Sunovion Pharmaceuticals Inc. ($145.47) |
| 2017 | $248.89 | 2 | GE HEALTHCARE ($138.16) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2023 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $110.46 | General |
| Category: Neurology | ||||||
| 02/22/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2020 | NATUS MEDICAL INCORPORATED | — | Food and Beverage | In-kind items and services | $21.01 | General |
| 01/21/2020 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: HBV | ||||||
| 09/04/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 08/20/2019 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $77.74 | General |
| Category: Orthopedic | ||||||
| 03/06/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $62.34 | General |
| 09/12/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $70.82 | General |
| Category: CNS | ||||||
| 06/19/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $130.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2018 | Abbott Laboratories | AMPLATZER Occluders (Device) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/21/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $62.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/20/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $74.65 | General |
| Category: CNS | ||||||
| 06/26/2017 | GE HEALTHCARE | DATSCAN (Drug) | Food and Beverage | Cash or cash equivalent | $138.16 | General |
| Category: CONTRAST MEDIA | ||||||
| 04/24/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $110.73 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 609 | 710 | $232,764 | $81,773 |
| 2022 | 8 | 708 | 865 | $262,672 | $98,729 |
| 2021 | 9 | 779 | 973 | $286,013 | $108,897 |
| 2020 | 11 | 534 | 606 | $167,391 | $56,995 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 124 | 148 | $59,809 | $22,697 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 133 | $37,753 | $13,250 | 35.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 46 | 46 | $24,258 | $8,508 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $24,670 | $7,864 | 31.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 68 | 68 | $22,304 | $7,305 | 32.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 107 | $19,177 | $7,250 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 44 | 49 | $12,524 | $4,114 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 34 | 34 | $11,220 | $3,677 | 32.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $8,748 | $2,779 | 31.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 21 | $5,472 | $2,119 | 38.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 13 | $4,479 | $1,532 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $2,350 | $675.99 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 229 | $60,691 | $24,819 | 40.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 94 | 126 | $44,478 | $19,420 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 101 | 101 | $40,501 | $13,494 | 33.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 74 | 129 | $22,317 | $8,053 | 36.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 58 | 59 | $19,352 | $7,042 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 72 | 86 | $21,586 | $6,937 | 32.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 33 | 33 | $16,599 | $6,344 | 38.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 42 | 42 | $13,860 | $4,554 | 32.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $10,692 | $3,422 | 32.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 12 | 12 | $5,772 | $1,812 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 13 | $4,394 | $1,723 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $2,430 | $1,107 | 45.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 157 | 215 | $56,545 | $24,528 | 43.4% |
About Dr. Mark Lin, MD
Dr. Mark Lin, MD is a Clinical Neurophysiology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104876713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Lin, MD has received a total of $1,213 in payments from pharmaceutical and medical device companies, with $14.28 received in 2024. These payments were reported across 17 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,213).
As a Medicare-enrolled provider, Lin has provided services to 2,630 Medicare beneficiaries, totaling 3,154 services with total Medicare billing of $346,394. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Clinical Neurophysiology
- Location Washington, DC
- Active Since 05/12/2006
- Last Updated 01/20/2010
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1104876713
Products in Payments
- APTIOM (Drug) $381.20
- DATSCAN (Drug) $138.16
- FARXIGA (Drug) $130.51
- Vemlidy (Drug) $120.00
- Exablate (Device) $110.46
- mild Device Kit (Device) $77.74
- UBRELVY (Drug) $67.08
- ELIQUIS (Drug) $62.83
- QULIPTA (Drug) $29.46
- AMPLATZER Occluders (Device) $12.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Neurophysiology Doctors in Washington
Adelaide Robb, Md, MD
Clinical Neurophysiology — Payments: $87,212
Jay Salpekar, Md, MD
Clinical Neurophysiology — Payments: $26,317
Miguel Macaoay, Md, MD
Clinical Neurophysiology — Payments: $1,401
Dr. Thanh Nguyen, Md, MD
Clinical Neurophysiology — Payments: $369.57
Robert Laureno, Md, MD
Clinical Neurophysiology — Payments: $85.23
Irene Chatoor, Md, MD
Clinical Neurophysiology